Clearance authorizes the commercial marketing of Encora X1 as a prescription wearable device to aid in the relief of hand tremors in the treated limb during stimulation in adults with essential tremor (ET).

The X1 device joins the wrist-worn, tremor-treating device market alongside the likes of Cala and Fasikl.

Encora X1, a non-invasive neurostimulation device, comes in at roughly the size of a typical smart watch. It senses tremor rhythm and delivers a customized stimulation that disrupts the tremor signal. This provides patients with stability and improved motor control during daily activities